by Scott Larrivee | Feb 19, 2025 | Podcast
On this episode of Talk Radioisotopes, hosts Scott Larrivee and Sarah Scouten interview Arjun Murthy, co-founder of Maven Bio, an AI-driven biopharma market intelligence platform. They explore how Arjun’s background, along with Maven Bio’s technology, is...
by Scott Larrivee | Feb 7, 2025 | News
WEST VALLEY CITY, Utah – Feb. 7, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CFO Pushkar Bedekar will present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11,...
by Scott Larrivee | Feb 5, 2025 | Podcast
On this episode, Talk Radioisotopes hosts Scott Larrivee and Sarah Scouten sit down with Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals. The discussion highlights Shaemus’s journey through the radiopharmaceutical industry, Clarity’s...
by Scott Larrivee | Jan 22, 2025 | News
VALENCIA, Calif. – Jan. 22, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at Piper Sandler’s Nex-Gen RadioPharma Symposium virtual event on Thursday, Jan. 23, 2025. The fireside...
by Scott Larrivee | Jan 22, 2025 | Podcast
On our first episode of ‘Talk Radioisotopes: Going Nuclear on Cancer,’ host Scott Larrivee is joined by co-host Dr. Sarah Scouten and guest Jeff Jones of Oppenheimer & Company.The discussion covers the latest trends in the radiopharmaceutical and...
